Siga Technologies INC Amortization of Debt Discount (Premium)
Siga Technologies INC (SIGA) reported Amortization of Debt Discount (Premium) of $37.82 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2013-11-06
- Siga Technologies INC amortization of debt discount (premium) for the quarter ending 2013-09-30 was $12.18K.
- Siga Technologies INC amortization of debt discount (premium) for the quarter ending 2013-06-30 was $12.92K.
- Siga Technologies INC amortization of debt discount (premium) for the quarter ending 2013-03-31 was $12.73K.
- Siga Technologies INC amortization of debt discount (premium) for the quarter ending 2012-09-30 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month |
|---|---|---|---|
| 2013-09-30 | $12.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $25.09K derived: sum of 2 quarters · filed 2013-11-06 | $37.82K 10-Q · filed 2013-11-06 |
| 2013-06-30 | $12.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $25.65K 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $12.73K 10-Q · filed 2013-05-15 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $0.00 10-Q · filed 2013-11-06 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |